Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(3 sites)
United States
Mayo Clinic in Arizona, Scottsdale, Arizona Mayo Clinic in Florida, Jacksonville, Florida Mayo Clinic in Rochester, Rochester, Minnesota